Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H7N5 |
Molecular Weight | 161.164 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NN=NN1C2=CC=CC=C2
InChI
InChIKey=ULIDRMKBVYYVIQ-UHFFFAOYSA-N
InChI=1S/C7H7N5/c8-7-9-10-11-12(7)6-4-2-1-3-5-6/h1-5H,(H2,8,9,11)
Fenamole is a muscle relaxant. It is effectively inhibits muscle spasms at good levels for a four hours and at significant levels for six hours. Clinical benefits were derived in patients with spasticity-spasm for periods up to 24 hours after a single oral dose. Fenamole is relatively free of adverse side effects particularly in the central nervous system. It is a potent copper chelator. It was once investigated as a potential antirheumatic agent in man.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Copper |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Sources: DOI: 10.1016/S0065-7743(08)60069-X (1974) Prostaglandin synthetase inhibitors, page 30, retrieved from: https://books.google.ru/books?id=dwxtAAAAMAAJ |
Palliative | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.google.com/patents/US3278381
800 mg single dose
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C80547
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
PRIMARY | |||
|
21640
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
PRIMARY | |||
|
DTXSID4048694
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
PRIMARY | |||
|
K4H264PBQ7
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
PRIMARY | |||
|
100000081262
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
PRIMARY | |||
|
DB12506
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
PRIMARY | |||
|
2079
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106224
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
PRIMARY | |||
|
25413
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
PRIMARY | |||
|
SUB07539MIG
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
PRIMARY | |||
|
226-780-4
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
PRIMARY | |||
|
5467-78-7
Created by
admin on Fri Dec 15 15:10:42 GMT 2023 , Edited by admin on Fri Dec 15 15:10:42 GMT 2023
|
PRIMARY |
ACTIVE MOIETY